General Information of the Protein
Protein ID |
PT01500
|
||||
---|---|---|---|---|---|
Protein Name |
Heat shock protein HSP 90-alpha
|
||||
Secondarily Protein Name |
Heat shock 86 kDa
Lipopolysaccharide-associated protein 2
Renal carcinoma antigen NY-REN-38
|
||||
Gene Name |
HSP90AA1
|
||||
Secondarily Gene Name |
HSP90A
HSPC1
HSPCA
|
||||
Sequence |
MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEDKEEEKEKEEKESEDKPEIEDVGSDEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Other cytosolic protein
|
||||
Function |
Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity which is essential for its chaperone activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function (PubMed:11274138, PubMed:15577939, PubMed:15937123, PubMed:27353360, PubMed:29127155, PubMed:12526792). Engages with a range of client protein classes via its interaction with various co-chaperone proteins or complexes, that act as adapters, simultaneously able to interact with the specific client and the central chaperone itself (PubMed:29127155). Recruitment of ATP and co-chaperone followed by client protein forms a functional chaperone. After the completion of the chaperoning process, properly folded client protein and co-chaperone leave HSP90 in an ADP-bound partially open conformation and finally, ADP is released from HSP90 which acquires an open conformation for the next cycle (PubMed:27295069, PubMed:26991466). Plays a critical role in mitochondrial import, delivers preproteins to the mitochondrial import receptor TOMM70 (PubMed:12526792). Apart from its chaperone activity, it also plays a role in the regulation of the transcription machinery. HSP90 and its co-chaperones modulate transcription at least at three different levels (PubMed:25973397). In the first place, they alter the steady-state levels of certain transcription factors in response to various physiological cues(PubMed:25973397). Second, they modulate the activity of certain epigenetic modifiers, such as histone deacetylases or DNA methyl transferases, and thereby respond to the change in the environment (PubMed:25973397). Third, they participate in the eviction of histones from the promoter region of certain genes and thereby turn on gene expression (PubMed:25973397). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Antagonizes STUB1-mediated inhibition of TGF-beta signaling via inhibition of STUB1-mediated SMAD3 ubiquitination and degradation (PubMed:24613385). Mediates the association of TOMM70 with IRF3 or TBK1 in mitochondrial outer membrane which promotes host antiviral response (PubMed:20628368, PubMed:25609812).
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Nucleus
Cytoplasm
Melanosome
Cell membrane
Mitochondrion
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000695 , CHL
Cell Line ID: CL000083 , MCF-7
Cell Line ID: CL000196 , MDA-MB-468
Cell Line ID: CL000013 , Sf9
Cell Line ID: CL000261 , SK-BR-3
Biochemical Assays
Clinical Information about the Protein
Target 1 ( Heat shock protein 90 alpha (HSP90A) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 8 Target-related Diseases | 8 | |||
1 | Respiratory tract inflammation [ICD-11: CA07] | ||||
2 | Asthma [ICD-11: CA23] | ||||
3 | Breast cancer [ICD-11: 2C60-2C65] | ||||
4 | Multiple myeloma [ICD-11: 2A83] | ||||
5 | Melanoma [ICD-11: 2C30] | ||||
6 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
7 | Peripheral nerve damage [ICD-11: ND56.4] | ||||
8 | Gastric adenocarcinoma [ICD-11: 2B72] | ||||
Approved Drug(s) | 2 Approved Drugs | 2 | |||
1 | Amlexanox | Approved | |||
2 | Cromoglicate | Approved | |||
Clinical Trial Drug(s) | 7 Clinical Trial Drugs | 7 | |||
1 | BIIB-021 | Phase 2 | |||
2 | NVP-AUY922 | Phase 2 | |||
3 | VER 50589 | Phase 2 | |||
4 | AT13387 | Phase 1 | |||
5 | Debio 0932 | Phase 1 | |||
6 | PU3 | Phase 1 | |||
7 | Tanespimycin | Phase 2 | |||
Discontinued Drug(s) | 2 Discontinued Drugs | 2 | |||
1 | Geldanamycin | Discontinued in Phase 2 | |||
2 | IPI-493 | Discontinued in Phase 1 | |||
Preclinical Drug(s) | 1 Preclinical Drug | 1 | |||
1 | CCT-018159 | Preclinical |